Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial
Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page
- CheckyesterdayChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAccess to the study page is blocked with a 403 Forbidden error, replacing the record content. The error page obscures the study details and navigation that were previously visible.SummaryDifference16%

- Check22 days agoChange DetectedThe page’s Revision line was updated from v3.6.6 to v3.7.0, signaling a newer version of the page. This appears to be a versioning or content update rather than a change to study results, eligibility, or participation details.SummaryDifference0.1%

- Check36 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page rendering. There are no changes to the study data or public content.SummaryDifference0.1%

- Check43 days agoChange DetectedNo textual changes detected on the Study Details page; observed differences appear to be related to visual/layout changes rather than content updates.SummaryDifference0.1%

- Check50 days agoChange DetectedThere are no text changes captured for this study page according to the provided data. The page content remains as originally published.SummaryDifference0.1%

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.